Mitsubishi Tanabe Pharma Canada, inc. Announces Publication Of Long-term Function And Survival Analysis Of RADICAVA® Oral Suspension (edaravone) – Treated Patients With ALS
Mitsubishi Tanabe Pharma Canada, inc. Announces Publication Of Long-term Function And Survival Analysis Of RADICAVA® Oral Suspension (edaravone) – Treated Patients With ALS